Pharmacist role in collaborative care


A panel of experts will discuss how the unique skills of pharmacists can be better utilised as part of a collaborative care model, at PSA17

The Primary Health Networks: collaborative roles of pharmacists in primary care and Health Care Homes panel session on Friday July 28 will explore ways to maximise the full potential of pharmacists in these roles.

PSA National Board Director Dr Shane Jackson will chair the expert panel session which will feature leading pharmacists working in collaborative care models in Australia including community pharmacy.

“We are looking forward to some lively discussion around innovative healthcare models, which have demonstrated significant benefits for patients, by employing care teams led by GPs and using an expanded staffing model in which nurses, pharmacists and others assume greater care management roles,” Dr Jackson says.

PHNs have been established with the key objectives of increasing the efficiency and effectiveness of medical services and improving coordination of care to ensure patients receive the right care in the right place at the right time.

The Health Care Home (HCH) is another model designed to help transform primary health care and improve the efficiency and effectiveness of the health system, particularly for consumers with chronic and complex conditions.

Dr Jackson says: “It’s vital for the pharmacy profession to consider how pharmacists working in community pharmacy or integrated within a general practice can address the needs of PHNs and the HCH.

“We invite all pharmacists to attend this important session to discover how they can play a greater part in this collaborative model of care and contribute to better health outcomes for patients in their local community,” Dr Jackson says.

PSA is partnering with the Commonwealth Pharmacists Association (CPA) to jointly host the PSA17 conference at Sydney’s newly refurbished Hyatt Regency Sydney at Darling Harbour from July 28–30, 2017.

To find out more, visit www.PSA17.com

Previous Codeine strategies at Pharmacy Connect
Next $825 million announced in pharmacy program changes

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.